An Institute for Clinical and Economic Review white paper states the potential benefits and challenges of several policy changes that could strengthen the accelerated approval pathway.
Medical Devices
AdvaMed Recommendations for Class 2 Notification Exemption
AdvaMed says it supports FDA efforts to expand exemptions from premarket notification for some Class 2 devices.
